Concepedia

Adam Ogden

AO

Statistics

Publications

13

Citations

671

H-Index

12

Active since

2002

Affiliations

Pfizer (United States)(Current)

University of Pennsylvania

The Ohio State University

Johns Hopkins University

Adam Ogden is an author at Pfizer (United States) specializing in pharmacology, medicine, and drug discovery.

Publications per year

2002–2019

13

Publications

13

A class of selective antibacterials derived from a protein kinase inhibitor pharmacophore

J. Richard Miller, Steve Dunham, Igor Mochalkin et al. · Proceedings of the National Academy of Sciences · 2009 · 160 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Addition of PNU-100480 to First-Line Drugs Shortens the Time Needed to Cure Murine Tuberculosis

Kathy N. Williams, Steven J. Brickner, C. Kendall Stover et al. · American Journal of Respiratory and Critical Care Medicine · 2009 · 127 citations

Medicine, Infectious Diseases, Pharmacology +15

Pentostatin in Steroid-Refractory Acute Graft-Versus-Host Disease

Javier Bolaños‐Meade, David A. Jacobsohn, Jeffrey Margolis et al. · Journal of Clinical Oncology · 2005 · 122 citations · Full text

Life Sciences, Hematology, Pharmacology +15

Photosensitive epilepsy

Rachel Gurrell, Donal Gorman, Mark Whitlock et al. · Neurology · 2019 · 38 citations

Medicine, Neurology, Pediatrics +16

Prediction of Efficacy of Vabicaserin, a 5‐HT<sub>2C</sub> Agonist, for the Treatment of Schizophrenia Using a Quantitative Systems Pharmacology Model

J Liu, Adam Ogden, TA Comery et al. · CPT Pharmacometrics & Systems Pharmacology · 2014 · 36 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

1–5 of 13